Pharmaceutical Quality Community

Thread Subject	Replies	Views	Last Post
WEBINAR: Patient Centric Specifications: Science, Risk, and Lifecycle Strategy	0	0	15 hours ago by Kim Huynh-Ba
FDA revised draft PSGs for generic peptides (comments due 28 Sep 2026)	0	3	2 days ago by Subathra Ramamoorthy
FDA draft guidance Biosimilar and Interchangeable Biosimilar Products: Considerations for Container Closure Systems and Device Constituent Parts	0	0	2 days ago by Subathra Ramamoorthy
Minutes from 07/24 PQ Meeting	0	2	9 days ago by Trevor Williams
FDA guideline for developing cell and gene therapy products	0	0	13 days ago by Kim Huynh-Ba
Friday, July 24th Pharmaceutical Quality Meeting	0	2	18 days ago by Trevor Williams
Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments; Reopening of the Comment Period	0	4	07-07-2026 by Masihuddin Jaigirdar
FDA revised draft: Demonstrating Substantial Evidence of Effectiveness (FDA-2019-D-4964)	0	6	07-07-2026 by Joseph Thomas
A new team - Excipients and Supply Chain Controls	3	14	07-06-2026 by David Schoneker Original post by Kim Huynh-Ba
Minutes from 06/26 PQ Meeting	0	5	07-03-2026 by Trevor Williams

Showing 1 to 10 of 33 threads (33 total posts)